Sign in

CIK 0001625297

  • Large accelerated filer

Supernus, Inc.

Sign in to watch
Ticker
SUPN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
412520873
Phone
+1 804-379-1090
Business address
9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
Former names
Indivior Pharmaceuticals, Inc., INDIVIOR PLC
Open-market buys, last 90 days
$53,535
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$53,535. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Anderson Woodrow D +$54K Chief Accounting Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-08-27 Anderson Woodrow D Chief Accounting Officer Purchase +1,500 $35.69 $54K 27,638
2026-08-05 Anderson Woodrow D Chief Accounting Officer Purchase +1,500 $36.28 $54K 26,138
2026-03-13 Ryan Barbara Director Purchase +8 $31.09 $249 5,724
2026-03-09 Ryan Barbara Director Purchase +31 $32.56 $1K 5,716
2026-03-06 Kingsley Stuart A Director Purchase +940 $31.87 $30K 5,582
2026-01-05 Humphreys Keith Director Purchase 10b5-1 +775 $35.39 $27K 5,802
2026-01-05 Ryan Barbara Director Purchase 10b5-1 +775 $35.39 $27K 1,963
2026-01-05 Wheadon David E. Director Purchase 10b5-1 +1,771 $35.39 $63K 14,395
2026-01-05 Stejbach Mark Director Purchase 10b5-1 +775 $35.39 $27K 16,847
2026-01-05 NINIVAGGI DANIEL A Director Purchase 10b5-1 +775 $35.39 $27K 16,923

Page 1 of 1 · 10 trades